eWeLL Beats FY2025 Forecasts as It Prepares Medium-Term Growth Push

eWeLL Co.,Ltd ( (JP:5038) ) just unveiled an update.

eWeLL reported strong results for the fiscal year ended December 2025, with fourth-quarter net sales rising 31.9% year on year and operating profit up 35.3%, both exceeding its earnings forecasts. The operating profit margin reached 45.3%, and although revenue was temporarily affected by the strategic deferral of billing for its AI Home-visit Scheduling & Routes service, growth in BPaaS and AI Plans & Reports largely offset the impact and supported a 15.6% increase in contract numbers and stable unit pricing.

eWeLL signaled that the current performance provides a base for its next medium-term business plan, which will prioritize future investment and profit expansion in its at-home medical care platform. By maintaining high margins while funding AI-driven and BPaaS offerings, the company aims to strengthen its position in Japan’s home-visit nursing market and capitalize on structural demand from the country’s looming 2040 aging-related challenges, with implications for sustained growth and enhanced value for stakeholders.

The most recent analyst rating on (JP:5038) stock is a Hold with a Yen2580.00 price target. To see the full list of analyst forecasts on eWeLL Co.,Ltd stock, see the JP:5038 Stock Forecast page.

More about eWeLL Co.,Ltd

eWeLL Co., Ltd. operates as an at-home medical care platform provider in Japan, focusing on electronic medical record systems for home-visit nursing care providers. The company targets the growing needs of a super-aging society and positions its services as core infrastructure supporting the shift toward at-home medical and nursing care.

Average Trading Volume: 83,991

Technical Sentiment Signal: Hold

Current Market Cap: Yen34.76B

See more insights into 5038 stock on TipRanks’ Stock Analysis page.